U.S. Physical Therapy Q2 Revenue Update

Ticker: USPH · Form: 10-Q · Filed: Aug 14, 2024 · CIK: 885978

Sentiment: neutral

Topics: quarterly-report, revenue, healthcare

TL;DR

USPH Q2 net patient revenue $179.5M, other revenue $38.6M. Six-month totals $357.7M and $76.6M.

AI Summary

U.S. Physical Therapy Inc. reported its second quarter 2024 results, with net patient revenues for the three months ended June 30, 2024, totaling $179.5 million. Other revenues, including management contracts and industrial injury prevention services, amounted to $38.6 million for the same period. For the six months ended June 30, 2024, net patient revenues were $357.7 million, and other revenues were $76.6 million.

Why It Matters

This filing provides insight into the company's revenue generation from its core physical therapy services and other related offerings, impacting investor understanding of its financial performance.

Risk Assessment

Risk Level: low — The filing is a routine quarterly report with no immediate red flags or significant negative developments.

Key Numbers

Key Players & Entities

FAQ

What were the total net patient revenues for U.S. Physical Therapy Inc. in the second quarter of 2024?

Net patient revenues for the three months ended June 30, 2024, were $179.5 million.

How much revenue did U.S. Physical Therapy Inc. generate from other sources in Q2 2024?

Other revenues, including management contract revenues and industrial injury prevention services revenues, were $38.6 million for the three months ended June 30, 2024.

What were the year-to-date net patient revenues as of June 30, 2024?

For the six months ended June 30, 2024, net patient revenues were $357.7 million.

What were the year-to-date other revenues as of June 30, 2024?

For the six months ended June 30, 2024, other revenues were $76.6 million.

What is the company's fiscal year end?

The company's fiscal year ends on December 31.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on August 14, 2024 regarding U S PHYSICAL THERAPY INC /NV (USPH).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing